Viking Global Investors LP Oric Pharmaceuticals, Inc. Transaction History
Viking Global Investors LP
- $25.1 Billion
- Q2 2024
A detailed history of Viking Global Investors LP transactions in Oric Pharmaceuticals, Inc. stock. As of the latest transaction made, Viking Global Investors LP holds 4,000,000 shares of ORIC stock, worth $38.7 Million. This represents 0.11% of its overall portfolio holdings.
Number of Shares
4,000,000
Previous 4,000,000
-0.0%
Holding current value
$38.7 Million
Previous $55 Million
48.58%
% of portfolio
0.11%
Previous 0.21%
Shares
1 transactions
Others Institutions Holding ORIC
# of Institutions
116Shares Held
63.2MCall Options Held
0Put Options Held
0-
Nextech Invest Ag5.29MShares$51.2 Million7.05% of portfolio
-
Black Rock Inc. New York, NY4.83MShares$46.8 Million0.0% of portfolio
-
Vr Adviser, LLC New York, NY4.39MShares$42.5 Million3.41% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA4.14MShares$40.1 Million1.73% of portfolio
-
Alkeon Capital Management LLC New York, NY3.8MShares$36.8 Million0.04% of portfolio
About Oric Pharmaceuticals, Inc.
- Ticker ORIC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,576,700
- Market Cap $383M
- Description
- ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...